tiprankstipranks
Advertisement
Advertisement

CH:NVAX Stock Latest News

Unusually active option classes on open September 2nd
The FlyUnusually active option classes on open September 2nd
2d ago
F
AUR
Novavax call volume above normal and directionally bullish
PremiumThe Fly
Novavax call volume above normal and directionally bullish
3d ago
NVAX
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
PremiumThe Fly
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
7d ago
SNY
TAK
Novavax call volume above normal and directionally bullish
PremiumThe Fly
Novavax call volume above normal and directionally bullish
15d ago
NVAX
Novavax call volume above normal and directionally bullish
PremiumThe Fly
Novavax call volume above normal and directionally bullish
15d ago
NVAX
Unusually active option classes on open August 19th
PremiumThe FlyUnusually active option classes on open August 19th
16d ago
ITB
LOW
Novavax call volume above normal and directionally bullish
Premium
The Fly
Novavax call volume above normal and directionally bullish
24d ago
NVAX
Trump Trade: President signs EO to split up of childhood vaccines
Premium
The Fly
Trump Trade: President signs EO to split up of childhood vaccines
24d ago
AZN
EBS
Trump signs EO to split up of childhood vaccines, Bloomberg reports
PremiumThe Fly
Trump signs EO to split up of childhood vaccines, Bloomberg reports
24d ago
AZN
EBS
Trump Trade: U.S. issues 15% duty on products made from polysilicon
PremiumThe Fly
Trump Trade: U.S. issues 15% duty on products made from polysilicon
28d ago
AZN
EBS
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
PremiumThe Fly
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
28d ago
AZN
EBS
Novavax reports Q2 EPS (32c), consensus (38c)
PremiumThe Fly
Novavax reports Q2 EPS (32c), consensus (38c)
29d ago
NVAX
Novavax raises 2026 adjusted revenue view to $235M-$275M from $230M-$270M
PremiumThe FlyNovavax raises 2026 adjusted revenue view to $235M-$275M from $230M-$270M
29d ago
NVAX
NVAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NVAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
NVAX
Federal health role nominee has record of vaccine skepticism, Stat News reports
Premium
The Fly
Federal health role nominee has record of vaccine skepticism, Stat News reports
2M ago
AZN
EBS
Novavax put volume heavy and directionally bearish
PremiumThe Fly
Novavax put volume heavy and directionally bearish
2M ago
NVAX
Novavax call volume above normal and directionally bullish
PremiumThe Fly
Novavax call volume above normal and directionally bullish
2M ago
NVAX
Novavax Shareholders Approve Directors, Pay and Incentive Plans
PremiumCompany Announcements
Novavax Shareholders Approve Directors, Pay and Incentive Plans
2M ago
8K
NVAX
Novavax put volume heavy and directionally bearish
PremiumThe Fly
Novavax put volume heavy and directionally bearish
2M ago
NVAX
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe FlyActing FDA head vows to block political interference, Endpoint News says
3M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
3M ago
AZN
BMY
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
Premium
The Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
4M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >